Prospective Evaluation of Asians With CRT for Heart Failure

Recruiting Observational Study
Heart Failure Cardiac Resynchronisation Therapy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
National University Heart Centre, Singapore · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Aim:To determine the baseline characteristics of heart failure patients in Singapore undergoing cardiac resynchronization therapy (CRT); the long term outcome and predictors of response to CRT. Methodology:Among patients undergoing CRT for severe heart failure according to indications stipulated in international Cardiology guidelines, baseline demographic data is collected. Age, gender, NYHA func…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Broad QRS (\>120 ms) * EF \< 40% * Symptomatic heart failure * Not on optimal medical therapy Exclusion Criteria: * Pregnant * \< 18 years of age * Infection * Unable to consent
Contacts

Pipin Kojodjojo, MD PHD

67795555

CONTACT